| Literature DB >> 34511799 |
Abstract
OBJECTIVES: Head and neck cancers are one of the most visible cancers permanently damaging appearances and affecting some of the very basic life functions of the patients. With advances in medical care and multidisciplinary team interventions, such changes can be managed and patient's quality of life (QOL) be improved. Thus, it is important to understand the QOL concerns of the patients. The objective of the study was to examine QOL concerns of the patients with head and neck cancer.Entities:
Keywords: Cancer; European Organization for Research and Treatment of Cancer Quality of Life Questionnaires; Head and neck cancer; Quality of life
Year: 2021 PMID: 34511799 PMCID: PMC8428896 DOI: 10.25259/IJPC_108_21
Source DB: PubMed Journal: Indian J Palliat Care ISSN: 0973-1075
Patients’ characteristics
| Patient’s characteristics | Percentage of respondents |
|---|---|
| Age (in years) | |
| 18–30 | 4 |
| 30–42 | 19 |
| 42–54 | 32 |
| 54–66 | 35 |
| 66–78 | 10 |
| Gender | |
| Male | 88 |
| Female | 12 |
| Marital status | |
| Married | 90 |
| Unmarried | 5 |
| Widow/Widower | 5 |
| Education | |
| Illiterate | 2 |
| Below Primary | 12 |
| Primary but below Secondary | 28 |
| Secondary to Sr. Secondary | 20 |
| Graduate | 33 |
| Postgraduation and above | 5 |
| Cancer category | |
| Oral cavity | 73 |
| Larynx | 11 |
| Oropharynx | 5 |
| Hypopharynx | 4 |
| Salivary glands | 3 |
| Nasopharyngeal | 1 |
| Nasal cavity | 1 |
| Unknown origin | 2 |
| Diagnostic stage | |
| Stage I | 9 |
| Stage II | 12 |
| Stage III | 24 |
| Stage IVa | 37 |
| Stage IVb | 5 |
| NA | 13 |
| Treatment status | |
| Ongoing curative | 62 |
| Follow-up | 38 |
| Total | 100 |
Descriptive statistics of the EORTC QLQ C-30.
| QLQ domains | Mean score (SD) | Percentage of patients | |
|---|---|---|---|
| Below average | Above average | ||
| Functional scale | |||
| Physical functioning | 71.50 (29.93) | 36 | 64 |
| Role functioning | 61.32 (40.19) | 42 | 58 |
| Emotional functioning | 50.45(35.83) | 49 | 51 |
| Cognitive functioning | 82.04(22.62) | 28 | 72 |
| Social functioning | 51.41(37.48) | 52 | 48 |
| Symptoms scale/item | |||
| Fatigue | 56.66 (33.59) | 56 | 44 |
| Nausea and vomiting | 8.16 (21.24) | 87 | 13 |
| Pain | 31.98(34.62) | 54 | 46 |
| Dyspnea | 18.99 (32.90) | 69 | 31 |
| Insomnia | 28.82 (38.39) | 58 | 42 |
| Appetite loss | 33.32 (36.69) | 45 | 55 |
| Constipation | 21.65 (34.60) | 67 | 33 |
| Diarrhea | 1.99 (12.39) | 97 | 3 |
| Financial difficulties | 60.81 (40.65) | 41 | 59 |
| Global QOL | 43.77 (31.98) | 48 | 52 |
EORTC QLQC: European Organization for Research and Treatment of Cancer Quality of Life Questionnaires Core, QOL: Quality of life
Descriptive statistics of EORTC QLQ HN 35.
| Symptom scale/item | Score mean (SD) | Percentage of patients | |
|---|---|---|---|
| Below average | Above average | ||
| Pain | 28.6 (29.2) | 63 | 37 |
| Swallowing | 52.9 (35.0) | 57 | 43 |
| Senses problems | 18.65 (27.34) | 70 | 30 |
| Speech problems | 45.63 (34.14) | 50 | 50 |
| Trouble with social eating | 56.26 (32.56) | 47 | 53 |
| Trouble with social contact | 53.99 (34.80) | 51 | 49 |
| Less sexuality | 27.90 (35.17) | 64 | 36 |
| Teeth | 45.98 (40.41) | 55 | 45 |
| Opening mouth | 55.65 (42.12) | 47 | 53 |
| Dry mouth | 63.98 (41.49) | 39 | 61 |
| Sticky saliva | 49.99 (46.29) | 49 | 51 |
| Coughing | 31.23 (40.70) | 56 | 44 |
| Felt ill | 65.98 (39.06) | 35 | 65 |
| Pain killers | 44.00 (49.88) | 56 | 44 |
| Nutritional supplements | 40.00 (49.23) | 60 | 40 |
| Feeding tube | 75.00 (43.51) | 25 | 75 |
| Weight loss | 35.00 (47.93) | 65 | 35 |
| Weight gain | 85.00 (35.88) | 15 | 85 |
EORTC QLQ HN: European Organization for Research and Treatment of Cancer Quality of Life Questionnaires Head and neck
Correlation of global QOL with various subscales.
| QOL subscales | Correlation with global QOL (r) |
|---|---|
| Physical functioning | 0.423** |
| Role functioning | 0.582** |
| Emotional functioning | 0.524** |
| Cognitive functioning | 0.328** |
| Social functioning | 0.458** |
| Fatigue | –0.505** |
| Nausea and vomiting | –0.302** |
| Pain | –0.342** |
| Dyspnea | –0.274** |
| Insomnia | –0.356** |
| Appetite loss | –0.232** |
| Constipation | –0.073 |
| Diarrhea | 0.138 |
| Financial difficulties | –0.452** |
P<0.01, QOL: Quality of life
Demographic variables and QOL.
| QOL scale | Age (r) | Gender (r) | Education (r) |
|---|---|---|---|
| Global QOL | –0.058 | –0.154 | 0.382** |
| Physical functioning | –0.097 | –0.150 | 0.203* |
| Role functioning | –0.053 | –0.015 | 0.160 |
| Emotional functioning | –0.082 | –0.091 | 0.252* |
| Cognitive functioning | –0.030 | 0.021 | –0.063 |
| Social functioning | 0.028 | –0.083 | 0.106 |
| Fatigue | 0.128 | 0.059 | –0.327** |
| Nausea and vomiting | –0.021 | 0.003 | –0.220* |
| Pain | –0.121 | 0.074 | –0.218* |
| Dyspnea | 0.248* | –0.026 | –0.173 |
| Insomnia | 0.024 | 0.003 | –0.250* |
| Appetite loss | 0.052 | 0.000 | –0.243* |
| Constipation | 0.178 | –0.054 | –0.058 |
| Diarrhea | 0.024 | 0.060 | 0.110 |
| Financial difficulties | –0.075 | –0.023 | –0.241* |
P<0.01, *P<0.05, QOL: Quality of life